KAT2A and acute myeloid leukemia: We found that KAT2A disruption was associated with a significant reduction in AML cell expansion (Figures 7A and 7B) and prolongation of mouse survival (Figure 7C), indicating that KAT2A inhibition suppresses AML cell proliferation in vivo.